$16.15
-3.69 (-18.60%)
Performance
1D
—
1W
—
1M
—
3M
-27.61%
6M
-35.81%
1Y
-42.32%
YTD
-40.14%
Open$16.80
Previous Close$19.84
Day High$17.39
Day Low$15.71
52W High$42.50
52W Low$16.28
Volume—
Avg Volume1.87M
Market Cap5.61B
P/E Ratio—
EPS$-0.25
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.57
Below
RSI (14)
21.6
Oversold
Analyst Ratings
Strong Buy
14 analysts
Price Target
+91.5% upside
Current
$16.15
$16.15
Target
$30.92
$30.92
$20.23
$30.92 avg
$48.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.69B | 1.64B | 1.52B |
| Net Income | -141,357,273 | 316.28M | 306.08M |
| Profit Margin | -8.4% | 19.3% | 20.1% |
| EBITDA | 51.13M | 415.16M | 429.14M |
| Free Cash Flow | — | 185.08M | 215.40M |
| Rev Growth | — | +14.2% | +10.8% |
| Debt/Equity | 0.66 | 0.26 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |